Comparison of formoterol, salbutamol and salmeterol in methacholine- induced severe bronchoconstriction

European Respiratory Journal

Volumn 13, Issue 5, 1999, Pages 988-992

  Politiek, M J ^a   Boorsma, M ^b   Aalbers, R ^a  

^a MARTINI HOSPITAL   (Netherlands)

^b Astra Pharmaceutica ^*  (Netherlands)

Author keywords

Asthma; Bronchoconstriction; Formoterol; Methacholine induced; Salbutamol; Salmeterol

Indexed keywords

FORMOTEROL; METHACHOLINE; SALBUTAMOL; SALMETEROL; SALMETEROL XINAFOATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; ADULT; ALBUTEROL; ASTHMA; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ETHANOLAMINES; FEMALE; HUMANS; MALE; METHACHOLINE CHLORIDE; TIME FACTORS;

EID: 0033062381     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.13e10.x     Document Type: Article

References (20)

1. American Thoracic Society. Standards for the diagnosis and care of patients with COPD and asthma. Am Rev Respir Dis 1987; 136: 225-244.
2. Global Initiative for Asthma. Global strategy for asthma management and prevention. Washington, D.C., National Heart, Lung, and Blood Institute, 1995 (Publication no. 95-3659).
3. The British Guidelines on Asthma Management. 1995 Review and position statement. Thorax 1997; 52 (Suppl. 1): S1-S21.
4. Schreurs AJM, Sinninghe Damsté HEJ, de Graaff CS, Greefhorst APM. A dose-response study with formoterol Turbuhaler as maintenance therapy in asthmatic patients. Eur Respir J 1996; 9: 1678-1683.
5. Van der Molen T, Postma DS, Turner MO, et al. Effects of the long-acting β-agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. Thorax 1997; 52: 535-539.
6. Fuller R. Safety of salmeterol in the treatment of asthma. Eur Respir Rev 1995; 5: 133-137.
7. Pauwels RA, Löfdahl C-G, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337: 1405-1411.
8. Wegener T, Hedenström H, Melander B. Rapid onset of action of inhaled formoterol in asthmatic patients. Chest 1992; 102: 535-538.
9. Palmqvist M, Persson G, Lazer L, Rosenborg J, Larsson P, Lötvall J. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency. Eur Respir J 1997; 10: 2484-2489.
10. Van Noord JA, Smeets JJ, Raaijmakers JAM, Bommer AM, Maesen FPV. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. Eur Respir J 1996; 9: 1684-1688.
11. Sterk PJ, Fabbri LM, Quanjer PhH, et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J 1993; 6: Suppl. 16, 53-83.
12. Mahadewsingh JV, Hamersma WBGJ, Schreurs AJM. Relative efficacy of three different inhalers containing salbutamol in patients with asthma. Eur J Clin Pharmacol 1996; 50: 467-469.
13. Löfdahl CG, Andersson L, Bondesson E, et al. Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstruction. Eur Respir J 1997; 10: 2474-2478.
14. Beach JR, Young CL, Stenton SC, Avery AJ, Walters EH, Hendrick DJ. A comparison of the speeds of action of salmeterol and salbutamol in reversing methacholine-induced bronchoconstriction. Pulm Pharmacol 1992; 5: 133-135.
15. Beach JR, Bromly CL, Avery AJ, Reid RWEC, Walters EH, Hendrick DJ. Speeds of action of single doses of formoterol and salbutamol compared with placebo in reversing methacholine-induced bronchoconstriction. Pulm Pharmacol 1996; 9: 245-249.
16. Tonnesen F, Laursen LC, Evald T, Stahl E, Ibsen TB. Bronchodilator effect of terbutaline powder in acute severe bronchial obstruction. Chest 1994; 105: 697-700.
17. Brown PH, Ning ACWS, Greening AP, McLean A, Crompton GK. Peak inspiratory flow through Turbuhaler in acute asthma. Eur Respir J 1995; 8: 1940-1941.
18. Smyth ET, Pavord ID, Wong CS, Wisniewski AFZ, Williams J, Tattersfield AK. Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. Br Med J 1993; 306: 543-545.
19. 2-adrenoceptor agonists with higher efficacy on guinea pig trachea and human bronchus in vivo. Br J Pharmacol 1994; 113: 687-692.
20. Maesen FPV, Costongs RJMG, Smeets JJ, Brombacher PJ, Zweers PGMA. The effect of maximal doses of formoterol and salbutamol from a metered-dose inhaler on pulse rates, ECG, and serum potassium concentrations. Chest 1991; 99: 1367-1373.